Patents by Inventor Jamal Mahajna

Jamal Mahajna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080019996
    Abstract: The invention relates to a method for treatment of chronic myelogenous leukemia (CML), Ph+ acute lymphoblastic leukemia (ALL), prostate cancer and ?-globin disorders such as sickle cell anemia and ?-thalassemia, comprising administration of a mycelium extract from at least one higher Basidiomycetes medicinal mushroom selected from the group consisting of Ganoderma adspersum, Hypsizygus ulmarium, Kuehneromyces mutabilis, Omphalotus olearius, Panus conchatus, Piptoporus betulinus, Pleurotus eryngii, and Trametes zonata.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 24, 2008
    Applicants: Gavish-Galilee Bio Applications Ltd., Carmel-Haifa University Economic Corp. Ltd.
    Inventors: Jamal MAHAJNA, Majed YASSIN, Solomon WASSER
  • Patent number: 7258862
    Abstract: The invention relates to a method for treatment of chronic myelogenous leukemia (CML), Ph+ acute lymphoblastic leukemia (ALL), prostate cancer and ?-globin disorders such as sickle cell anemia and ?-thalassemia, comprising administration of a mycelium extract from at least one higher Basidiomycetes medicinal mushroom selected from the group consisting of Ganoderma adspersum, Hypsizygus ulmarium, Kuehneromyces mutabilis, Omphalotus olearius, Panus conchatus, Piptoporus betulinus, Pleurotus eryngii, and Trametes zonata.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: August 21, 2007
    Assignees: Gavish-Galilee Bio Aplications Ltd., Carmel-Haifa University Economic Corp.
    Inventors: Jamal A. Mahajna, Majed Yassin, Solomon P. Wasser
  • Publication number: 20060057157
    Abstract: The invention relates to a method for treatment of chronic myelogenous leukemia (CML), Ph+ acute lymphoblastic leukemia (ALL), prostate cancer and ?-globin disorders such as sickle cell anemia and ?-thalassemia, comprising administration of a mycelium extract from at least one higher Basidiomycetes medicinal mushroom selected from the group consisting of Ganoderma adspersum, Hypsizygus ulmarium, Kuehneromyces mutabilis, Omphalotus olearius, Panus conchatus, Piptoporus betulinus, Pleurotus eryngii, and Trametes zonata.
    Type: Application
    Filed: October 25, 2005
    Publication date: March 16, 2006
    Applicants: Gavish-Galilee Bio Applications Ltd., Carmel-Haifa University Economic Corp. Ltd.
    Inventors: Jamal Mahajna, Majed Yassin, Solomon Wasser
  • Publication number: 20060045887
    Abstract: The invention relates to compositions comprising a mycelium extract from at least one higher Basidiomycetes medicinal mushroom selected from the group consisting of Ganoderma adspersum, Hypsizygus ulmarium, Kuehneromyces mutabilis, Omphalotus olearius, Panus conchatus, Piptoporus betulinus, Pleurotus eryngii, and Trametes zonata, said composition having selective antiproliferative activity on the human chronic myelogenous leukemia K562 cells and on the human prostate cancer LNCaP cells. The compositions are useful for treatment of chronic myelogenous leukemia (CML), Ph+ acute lymphoblastic leukemia (ALL), prostate cancer and ?-globin disorders such as sickle cell anemia and ?-thalassemia.
    Type: Application
    Filed: August 25, 2004
    Publication date: March 2, 2006
    Applicants: Gavish-Galilee Bio Applications Ltd., Carmel-Haifa University Economic Corp. Ltd.
    Inventors: Jamal Mahajna, Majed Yassin, Solomon Wasser